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Abstract
Introduction
The combination of hypothermic and normothermic machine perfusion (HMP+NMP) of
the liver provides individual benefits of both techniques, improving the rescue of marginal
organs. The aim of this study was to investigate the effect on the bioenergetic status and the
oxidative-mediated tissue injury of an uninterrupted combined protocol of HMP+NMP using
a single haemoglobin-based oxygen carrier (HBOC)-based perfusate.
Methods
Ten discarded human donor livers had either 2 hours of dual hypothermic oxygenated perfu-
sion (D-HOPE) with sequential controlled rewarming (COR) and then NMP using the
HBOC-based perfusate uninterruptedly (cold-to-warm group); or 2 hours of hypothermic
oxygenated perfusion (HOPE) with an oxygen carrier-free perfusate, followed by perfusate
exchange and then NMP with an HBOC-based perfusate. Markers of liver function, tissue
adenosine triphosphate (ATP) levels and tissue injury were systematically assessed.
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Results
The hypothermic phase downregulated mitochondrial respiration and increased ATP levels
in both groups. The cold-to-warm group presented higher arterial vascular resistance during
rewarming/NMP (p = 0.03) with a trend of lower arterial flow (p = 0.09). At the end of NMP
tissue expression of markers of reactive oxygen species production, oxidative injury and
inflammation were comparable between the groups.
Conclusion
The uninterrupted combined protocol of HMP+NMP using an HBOC-based perfusate—
cold-to-warm MP—mitigated the oxidative-mediated tissue injury and enhanced hepatic
energy stores, similarly to an interrupted combined protocol; however, it simplified the logis-
tics of this combination and may favour its clinical applicability.
Background
Ex situ machine perfusion (MP) demonstrates superior preservation for extended criteria
donor (ECD) livers [1–3]. The MP field has largely focused on oxygenated hypothermic MP
(HMP) and normothermic MP (NMP) to date, and both MP techniques have reported benefits
over standard static cold storage [3–5]. There remains controversy as to whether markers of
liver injury and function are comparable between HMP and NMP [6, 7]. Preclinical and clini-
cal studies have recently suggested that a combined protocol of HMP and NMP is feasible and
it may derive individual benefits of both techniques [8–11].
The inability to utilise a red blood cell-based perfusate during HMP, owing to the risk of
sludging [12] and haemolysis [9] at hypothermia as well as the need for an oxygen carrier dur-
ing NMP, imposes the need for perfusate exchange during the perfusion process if one wishes
to combine both techniques, as it was previously done by our research group [8]. This inter-
ruption in the perfusion process adds an unnecessary ischaemic time to the organs, which may
hinder the implementation of the combined protocol of HMP and NMP.
Haemoglobin-based oxygen carriers (HBOC) have an advantage that can potentially be
used under a wide range of temperatures with reports on HMP, subnormothermic MP at 20
˚C and NMP [9, 13, 14]. In addition, it would allow gradual rewarming of the organs (con-
trolled oxygenated rewarming [COR]), which has also been suggested to mitigate reperfusion
injury and improve graft function post-transplantation [11, 15, 16].
It was then hypothesised that the use of a single HBOC-based perfusate for a combined per-
fusion from cold to warm might eliminate entirely any concerns of exposing the organs to
additional unnecessary ischaemia time, required for perfusate exchange, optimising the logis-
tics of a combined perfusion, thereby increasing its clinical applicability. This hypothesis was
tested clinically in two recent studies [9, 11]. While the authors have shown the clinical feasibil-
ity of this combined protocol, they were not able to investigate markers of oxidative tissue
injury, activation of the inflammatory cascade and replenishment of hepatic adenosine tri-
phosphate (ATP) levels. These analyses are crucial because the hypothermic phase in the com-
bined protocol aims specifically to increase hepatic ATP content and mitigate the harmful
impact of the oxidative tissue injury [3].
The aim of this study was to investigate the effect on oxidative tissue damage, activation of
inflammatory markers and hepatic ATP content of a combined protocol of HMP and NMP—
dual hypothermic oxygenated perfusion (D-HOPE) with sequential slow COR and NMP—
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using a single HBOC-based perfusate throughout; and compare these results with those from a
previously published interrupted combined protocol which has used an HBOC-based perfus-
ate only for the NMP phase, requiring perfusate exchange during the perfusion run [8].
Materials and methods
Ten discarded human livers were sequentially allocated to two experimentally matched groups:
(1) the HOPE+NMP group that had two hours of hypothermic oxygenated perfusion (HOPE),
using a Belzer MPS1UW Machine Perfusion Solution (UW-MPS) (Bridge to Life, London,
UK) as the perfusate, followed by NMP employing an HBOC-based perfusate (Hemopure1—
haemoglobin glutamer-250 [bovine]; HBOC-201, Hemoglobin1Oxygen Therapeutics LLC,
Cambridge, USA) (previously published group [8]); and (2) the cold-to-warm group—this
group had an HBOC-based perfusate starting at time 0 that permitted simplifying changes to
the protocol: hepatic artery (HA) and portal vein (PV) were cannulated during commence-
ment and D-HOPE was carried out for the hypothermic phase. Following this, the organs
were gradually rewarmed (COR) and then had NMP for viability assessment. The total perfu-
sion time was six hours for both groups. Perfusate, bile and tissue biopsies were sampled sys-
tematically. The detailed sampling protocol is presented in Fig 1.
Source of discarded human livers
All livers were retrieved with the intention of clinical transplantation according to the National
Organ Retrieval Service standards. After the procurement, they were stored on ice in Belzer
University of Wisconsin (UW1) Cold Storage Solution (Bridge to Life) and then rejected for
transplantation by all transplant centres in the United Kingdom and offered for research by
the National Health Service Blood and Transplant (NHSBT) coordinating office. Specialist
nurses in organ donation obtained consent to use donor tissue for research as part of the con-
sent process for standard clinical organ donation. None of the donor organs were from a vul-
nerable population and all next of kin provided written informed consent that was freely
given. The study’s ethical approval was obtained from the London-Surrey Borders National
Research Ethics Service and the NHSBT Ethics Committee (references 13/LO/1928 and 06/
Q702/61, respectively).
Organ preparation and machine perfusion procedure
After arrival at our centre, the livers had a standard bench preparation as described elsewhere
[17] followed by flushing with two litres of 5% glucose solution. The Liver Assist Device (Organ
Assist, Groningen, Netherlands) was applied for MP. The perfusate temperature and perfusion
pressures were set by the operator as specified in the Supplementary Material. The measured
flow rates and calculated resistances, as shown on the device’s display in real time, were
recorded every 30 minutes. Oxygen was supplied via a Sechrist air/oxygen blender (S3500CP-G,
Inspiration Healthcare, Ltd., Leicester, United Kingdom). The fraction of inspired oxygen was
set initially at 30% with a flow of 1–2 L/min and adjusted to achieve the target oxygen perfusate
pressure for each modality of perfusion as specified in the Supplementary Material. A detailed
description of the techniques underlying MP performed in this study is presented in the Supple-
mentary Material, and the composition of the HBOC-based perfusate is found in S1 Table.
Assessment of liver metabolism
The perfusate was sampled every 30 minutes throughout the perfusion in both groups and ana-
lysed immediately for blood gases or snap-frozen and stored for later analyses. Bile produced
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during the perfusion was collected via a 12-Fr silicon tube inserted into the common bile duct,
weighed at 4 and 6 hours of MP and immediately analysed at 6 hours. Both, bile and perfusate
samples, were assessed using a Cobas b 221 (Roche Diagnostics, Indianapolis, IN) point-of-
care system blood gas analyser. Perfusate parameters included partial pressure of oxygen
(PO2) and partial pressure of carbon dioxide (PCO2), pH, base excess, bicarbonate, oxygen sat-
urations, haemoglobin, haematocrit, glucose and lactate concentrations. For bile samples, bile
pH and glucose concentrations were analysed.
Oxygen uptake was calculated during HOPE perfusion (oxygen carrier-free-based perfus-
ate) as the oxygen inflow minus the outflow in kPa, corrected by liver weight. For the HBOC-
Fig 1. Study design. Donor human livers had standard procurement, they were cold flushed and stored. Once rejected
for transplantation, they were offered for research and consecutively allocated to the two experimental groups. Image A
shows the protocol for the HOPE+NMP group, livers had hypothermic oxygenated perfusion (HOPE) using Belzer
MPS1UW Machine Perfusion Solution for 2 hours. HOPE was performed at 10 ˚C via the portal vein only, as
represented on image C. After 2 hours, the perfusate was changed to an acellular haemoglobin-based oxygen carrier
(HBOC) Hemopure1 (HBOC-201, Hemoglobin1Oxygen Therapeutics LLC, Cambridge, USA)-based perfusate for the
rewarming and normothermic machine perfusion (NMP). The livers from the cold-to-warm group (Image B) were fully
cannulated at the start of the perfusion, including portal vein, hepatic artery and common bile duct (Image D). They
received the HBOC-based perfusate from time 0. For this group, the livers had 2 hours of dual hypothermic oxygenated
perfusion (D-HOPE) at 10 ˚C followed by 1 hour of slow rewarming to 20 ˚C (controlled oxygenated rewarming [COR])
and then NMP. Menghini and wedge biopsies were collected at time 0, 2 and 6 hours (��) and immediately fixed in
formalin or snap-frozen in liquid nitrogen. Blood gas analysis was carried out and perfusate was sampled at 30 min time
intervals throughout. In addition, bile production was measured at time 4 and 6 hours (#) and analysed at 6 hours.
https://doi.org/10.1371/journal.pone.0224066.g001
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based perfusate, the oxygen consumption was calculated from the difference between the oxy-
gen content after the oxygenator and return into the oxygenator within the venous circuit.
Oxygen content was calculated as the sum of the free dissolved oxygen fraction and the haemo-
globin-bound oxygen fraction (equation located in the Supplementary Methods) as described
elsewhere [18].
The recovery of appropriate liver metabolism was assessed during NMP by our unit’s pub-
lished criteria. The major criterion was perfusate lactate levels < 2.5 mmol/L, in association
with the evidence of bile production, glucose consumption, stable vascular flows and homoge-
neous parenchymal perfusion [19, 20].
Histopathological assessment of hepatocyte injury
Liver biopsies obtained prior to and at the end of perfusion were immediately fixed in forma-
lin, processed and embedded in paraffin. Thereafter, 4 μm sections were cut and stained with
haematoxylin and eosin (H&E) as well as periodic acid Schiff (PAS). H&E sections were semi-
quantitatively graded for ischaemic-type coagulative necrosis, macrovesicular steatosis (large
lipid droplets filling up the hepatocytes and displacing the nucleus to the periphery) and pre-
existing liver disease. The PAS-stained sections were scored for the percentage of positive
areas of glycogen, and the variation between the beginning and end of the perfusion was com-
pared across groups. Histological assessment was blinded and conducted by an experienced
liver transplant pathologist.
Immunohistochemical assessment of oxidative stress and tissue
inflammation
Immunohistochemistry was performed on formalin-fixed paraffin-embedded sections to
assess surrogate markers of oxidative injury and tissue inflammation. Uncoupling protein 2
(UCP2) was assessed for reactive oxygen species (ROS) production [21–23]. Oxidative tissue
injury was evaluated by the expression of 4-hydroxynonenal (4-HNE), a product of lipid per-
oxidation in cells. For the assessment of tissue inflammation, we analysed the following mark-
ers: (1) cluster of differentiation (CD)14, a lipopolysaccharide receptor which is part of the
toll-like receptor 4 signalosome [24–26]; (2) CD11b is an integrin on the surface of leukocytes;
upregulation of its expression indicates activation of the cells by substances, including ROS
[27, 28]; and (3) the vascular cell adhesion molecule 1 (VCAM-1), a cell adhesion molecule
expressed in cytokine-activated endothelial cells that mediates leukocyte transendothelial
migration. All primary antibodies were detected using specific ImmPRESS™ Excel Amplified
HRP Polymer Staining kits (Vector Laboratories, Burlingame, CA, USA) specific to the respec-
tive mouse or rabbit immunoglobulin isotype. A list of primary antibodies and dilutions used
is provided in the Supplementary Material.
Four images of each section, excluding the edges, were randomly selected for analysis (×400
magnification). A semiquantitative scoring system, the modified immunoreactive score (IRS)
[29], was obtained by multiplying the score for intensity (0: no colour reaction; 1: mild reac-
tion; 2: moderate reaction; 3: intense reaction) and distribution (0: no positive cells; 1:<10%
positive cells; 2: 10–50% positive cells; 3: 51–80% positive cells; 4: >80% positive cells) to
obtain a final score between 0 and 12. The change in overall tissue expression of staining
(ΔIRS) was determined by subtracting the IRS score after 6 hours of perfusion from the score
prior to perfusion: negative values indicated a decrease and positive values an increase in the
expression of staining.
The cold-to-warm machine perfusion of the liver
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Assessment of tissue adenosine triphosphate (ATP) levels
Quantification of ATP was carried out by homogenisation of liver tissue. The concentration
was determined with the ATP Bioluminescent Assay kit (FLAA, Sigma-Aldrich Inc, St Louis,
USA). More details are provided in the Supplementary Material.
Statistical analysis
Continuous variables were expressed as median with interquartile range (IQR) and categorical
variables as the absolute number with percentage frequencies. Comparisons between groups
were performed via Fisher’s exact test for categorical variables, the Mann—Whitney U test for
independent continuous variables and the Wilcoxon signed-rank test for repeated measure-
ments over time on the same sample. The statistical level of significance was set at p< 0.05.
GraphPad Prism (version 6.04 for Windows, GraphPad Software, La Jolla, USA) software was
employed for graph creation and all statistical analyses were carried out with the Statistical
Package for the Social Sciences version 22 software (IBM Corp, Armonk, NY).
Results
Donor demographics and organ characteristics
The median donor age for all livers was 54 years (IQR: 51–55), donor body mass index 31 kg/
m2 (24–36) and donor risk index 2.1 (2.0–2.6). Median cold ischaemia time was 663 minutes
(510–712) and warm ischaemia time for donors after circulatory death (DCD) 8 minutes (7–
31). Detailed donor demographics and donor organ characteristics are presented in Table 1.
Each experimental group had three DCD livers and the groups were comparable regarding
donor and liver characteristics (Table 2).
Stability of an HBOC-based perfusate at variable temperatures
Haemoglobin levels of the HBOC-perfusate were comparable between the start and end of the
hypothermic phase (D-HOPE) (53.2 [44.7–65.6] vs. 52.8 [42.5–64.7] g/dL, p = 0.59). At the
beginning of the COR phase, antibiotics and other supplements (specified in S1 Table) were
added to the HBOC-based perfusate, to supply the increasing metabolic demand of the organs
over the next perfusion stages, and a dilutional effect was observed between 2 and 3 hours. The
median haemoglobin levels were similar at the end of NMP between the groups (HOPE+NMP
46.7 [42.9–47.7] vs. cold-to-warm 47.5 [38.2–50.4] g/dL). Methaemoglobin (MetHb) levels
were stable during the D-HOPE and COR phases and then rose with the rewarming/NMP
phase. Despite this trend, the levels of oxygen saturation were constant. Details are found in
Fig 2.
The effectiveness of an HBOC-based perfusate on mitochondrial
respiration and energy replenishing during the hypothermic phase
During the HOPE phase, the livers exhibited downregulation of mitochondrial respiration
with a decrease in the oxygen uptake rate and CO2 release with the perfusate. Similarly, during
D-HOPE, the livers experienced a fall in oxygen consumption rate from time 0 to 2 hours
(2.68 [2.35–3.02] vs. 1.24 [1.11–4.47] mLO2/min/kg liver, p = 0.10) with a drop in pCO2 levels,
reaching similar levels at 2 hours (HOPE+NMP 0.8 [0.6–1.0] vs. cold-to-warm 1.2 [1.0–1.7]
kPa, p = 0.28). Pre-perfusion ATP levels were comparable between groups (p> 0.99). At the
end of 2 hours HMP, ATP levels rose 1.8-fold in the HOPE+NMP group and 2.5-fold in the
cold-to-warm group. See further details in Fig 2.
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Table 1. Donor demographics, liver characteristics and machine perfusion parameters.
Liver number Cold-to-
warm 1
Cold-to-
warm 2
Cold-to-
warm 3
Cold-to-
warm 4
Cold-to-
warm 5
HOPE+NMP
1
HOPE+NMP
2
HOPE+NMP
3
HOPE
+NMP 4
HOPE
+NMP 5
Donor information
Age 73 51 55 57 52 54 50 54 38 55
Donor type DBD DCD DBD DCD DCD DCD DBD DBD DCD DCD
Sex Male Male Male Female Female Male Female Female Male Female
Height (cm) 164 189 172 160 160 179 158 170 183 160
Bodyweight (kg) 90 76 85 70 90 123 60 87 85 90
Body mass index (kg/m2) 33 21 29 27 35 38 24 30 25 35
US—Donor risk index 2.0 2.1 2.0 2.5 2.9 2.5 2.0 1.9 1.8 3.0
UK—donor liver index 1.4 1.8 1.1 1.9 2.1 1.8 1.1 1.0 1.8 1.9
ET—donor risk index 2.0 2.7 2.0 2.5 2.8 2.9 2.2 1.9 2.3 2.8
Peak ALT (IU/L) 33 74 72 135 81 189 14 271 37 741
Days on ventilator 4 3 2 11 4 5 2 2 4 4
Co-morbidities and risk
history
HTN Smoker Diabetes
(type 2)
Alcohol
misuse
Smoker,
HTN
Diabetes
(type 2)
HTN
Smoker,
Alcohol
misuse
Diabetes
(type 1),
Smoker
Active
Smoker
HTN
Cause of death HBD HBD ICH ICH HBD HBD ICH ICH ICH HBD
Liver characteristics
Liver weight (g) 1652 1900 1920 2140 1598 2600 1838 2060 1753 1935
Donor warm ischaemic
time (minutes)
NA 8 NA 10 14 31 NA NA 42 8
Cold ischaemic time
(minutes)
532 645 793 430 934 497 682 491 660 510
Retrieval location Regional Extra-
zonal
Extra-
zonal
Regional Extra-
zonal
Extra-zonal Extra-zonal Extra-zonal Extra-
zonal
Extra-zonal
Reason for clinical rejection Donor
cancer
Steatosis Steatosis Steatosis Donor
cancer
Poor flush Steatosis Steatosis Poor
flush
Steatosis,
poor flush
Large droplets
macrovesicular steatosis
(paraffin sections)
0% 0% 20% 40% 0% 10% 0% 15% 3% 30%
Machine perfusion parameters—throughout entire duration of perfusion
Lactate (mmol/L)
Highest 6.7 9.1 12.0 12.6 10.2 9.1 8.9 10.4 4.6 7.8
Lowest 0.3 0.7 5.1 2.4 0.2 0.6 1.1 1.8 0.2 0.8
At the end of 6-hour
perfusion
0.3 0.7 6.3 2.4 0.2 0.6 1.1 1.8 0.2 0.8
Total Bile production (g) 5.0 3.2 0.0 10.0 0.0 57.0 0.0 0.0 15.9 24
Mean Arterial flow (mL/
min)
92 102 132 77 127 292 299 234 152 398
Mean Portal vein flow (mL/
min)
636 619 390 322 451 1412 1523 1602 1406 1582
Mean liver mass perfusion
(mL/g/min)
0.4 0.4 0.3 0.2 0.4 0.7 1.0 0.9 0.9 1.0
Viability criteria met Yes Yes No Yes Yes Yes Yes Yes Yes Yes
Abbreviations: HOPE: hypothermic oxygenated perfusion of the liver; NMP: Normothermic machine perfusion of the liver; DCD: donation after circulatory death;
DBD: donation after brain death; US: United States; UK: United Kingdom; ET: Eurotransplant; ALT: alanine aminotransferase; HTN: hypertension; ICH: intracranial
haemorrhage; HBD: hypoxic brain damage; NA: not applicable.
Note: Donor warm ischaemic time was defined as the interval between the systolic blood pressure less than 50 mmHg or/and arterial oxygen saturation to less than 70%
to commencing the aortic cold perfusion in the donor.
https://doi.org/10.1371/journal.pone.0224066.t001
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The effect of hypothermic perfusion on the rewarming and normothermic
phases
During the COR phase, oxygen consumption increased slightly and reached 4.06 mLO2/min/
kg liver (3.66–4.47). After rewarming during the NMP phase, despite not being statistically sig-
nificant, the peak of oxygen consumption was higher for the cold-to-warm group (138.60
[52.26–149.19] vs. 75.89 [59.22–89.72] mLO2/min/kg, p = 0.22). The CO2 levels increased
steadily for the cold-to-warm group during the NMP phase and were stable for the HOPE
+NMP group. At the end of the perfusion run, the levels of ATP increased 2.7-fold in the
HOPE+NMP group and 5.8-fold in the cold-to-warm group (Fig 3).
Vascular flow dynamics
Median arterial vascular resistances were high during D-HOPE (0.3 mmHg/mL/min/kg) and
decreased slightly during the COR phase (0.2 mmHg/mL/min/kg). When the arterial
Table 2. Donor demographics, liver characteristics and machine perfusion data.
Liver number Cold-to-Warm (n = 5) HOPE+NMP (n = 5) p-value
Donor information
Age, years 55 (52–57) 54 (46–54) 0.87
DCD livers 3 (60%) 3 (60%) >0.99
Sex, male 3 (60%) 2 (40%) 0.53
Height (cm) 164 (160–172) 179 (169–181) 0.11
Bodyweight (kg) 85 (76–90) 90 (87–106) 0.98
Body mass index (kg/m2) 29 (27–33) 35 (30–37) 0.73
Donor risk index 2.1 (2.0–2.5) 2.5 (2.2–2.7) 0.20
UK donor liver index 1.8 (1.2–2.0) 1.8 (1.0–1.8) 0.55
ET donor risk index 2.5 (2.0–2.8) 2.3 (2.0–2.8) 0.84
Peak ALT (IU/L) 74 (72–81) 189 (37–271) 0.18
Days on ventilator 4 (3–4) 4 (2–4) 0.45
Liver characteristics
Liver weight (g) 1900 (1749–2020) 1935 (1838–2060) 0.58
Donor warm ischaemic time (minutes) 8 (6–11) 31 (19–36) 0.10
Cold ischaemic time (minutes), DCD 705 (537–789) 682 (586–708) 0.86
Cold ischaemic time (minutes), DBD 658 (523–793) 586 (490–682) 0.93
Macrovesicular steatosis (%) 0 (0–30) 10 (1–22) 0.97
Machine perfusion parameters—throughout entire duration of perfusion
Lactate (mmol/L)
Highest 10.2 (9.1–12.0) 8.9 (7.8–9.1) 0.37
Lowest 0.7 (0.3–2.4) 0.8 (0.6–1.1) 0.45
Last 0.7 (0.3–2.4) 0.8 (0.6–1.1) 0.45
Total Bile production (g) 4 (0–6) 16 (0–40) 0.20
Abbreviations: NMP: normothermic machine perfusion of the liver; HOPE: hypothermic oxygenated perfusion of
the liver; DCD: donation after circulatory death; UK: United Kingdom; ET: Eurotransplant; ALT: alanine
aminotransferase; DBD: donation after brain death.
Note: Continuous variables presented as median and interquartile range, dichotomous variables as absolute number
and percentage. Donor warm ischaemic time was defined as the interval between the systolic blood pressure less than
50 mmHg or/and arterial oxygen saturation to less than 70% to commencing the aortic cold perfusion in the donor.
https://doi.org/10.1371/journal.pone.0224066.t002
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perfusion was started in the HOPE+NMP group, HA vascular resistance was lower than in the
cold-to-warm group (0.2 [0.1–0.3] vs. 0.4 [0.3–0.7] mmHg/mL/min/kg, p = 0.03). It remained
significantly lower in the HOPE+NMP group until 5 hours of perfusion and then decreased
for the cold-to-warm group, reaching a non-significant difference at the end of the normother-
mic phase (0.1 [0.1–0.2] vs. 0.2 [0.1–0.2] mmHg/mL/min/kg, p = 0.22). Despite a non-signifi-
cant difference at the beginning, at the end of the NMP, the median flow rates for HA were
comparable between groups (HOPE+NMP 365 [256–388] vs. cold-to-warm 310 [250–332]
mL/min).
A maximum portal venous pressure of 5 mmHg was used for the cold-to-warm group to
overcome the higher vascular resistance (Fig 4). This was kept at 3 mmHg for the HOPE
+NMP group. The difference in flow rates for PV did not reach statistical significance; how-
ever, values were higher for the HOPE+NMP group at the beginning of the HMP phase (280
[175–405] vs. 170 [130–300] mL/min) and at the end (320 [185–360] vs. 150 [125–305] mL/
min). At the end of the NMP, both groups had adequate PV flow (HOPE+NMP 1740 [1140–
1675] vs. cold-to-warm 1600 [1210–1740] mL/min). Fig 4 portrays the vascular flow and resis-
tance over the time of the perfusion.
Fig 2. Stability of HBOC-based perfusate at different temperatures and its impact on mitochondrial function at hypothermic
temperatures. Panel A shows on the left-hand graph that haemoglobin levels were stable during the D-HOPE phase, and after
rewarming, they were similar to the HOPE+NMP group that received fresh HBOC-based perfusate. Methaemoglobin levels (middle
graph) were stable during D-HOPE and increased slowly during the rewarming, reaching comparable levels to the HOPE+NMP group
during the normothermic phase. Despite the increase in the levels of methaemoglobin, arterial oxygen saturation was constant
throughout the perfusion. Panel B compares markers of mitochondrial respiration between the study groups. Both groups presented a
downward trend in oxygen requirements (oxygen uptake—HOPE+NMP group and oxygen consumption—cold-to-warm group), with a
similar drop in the release of carbon dioxide (CO2) in the perfusate. Reflecting an efficient mitochondrial oxidative function, both
groups replenished adenosine trisphosphate (ATP) stores during the hypothermic phase. In the graphs, dots represent individual organs
at the time points, and the line is the median of the values for each group. For the bar graph, the median and interquartile range are
represented.
https://doi.org/10.1371/journal.pone.0224066.g002
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Assessment of metabolic parameters during normothermic machine
perfusion
Perfusate lactate levels were similar at the start of the perfusion (HOPE+NMP 4.7 [2.5–7.4] vs.
cold-to-warm 6.6 [4.9–9.1] mmol/L, p = 0.31). Those levels were constant for the HOPE
+NMP group and increased for the cold-to-warm group, reaching higher levels at the end of
Fig 3. Mitochondrial and hepatic functional markers during the normothermic phase. Panel A shows a similar incremental rate of
oxygen consumption during the rewarming period, which finally culminated in a higher peak at the beginning of the normothermic
phase for the cold-to-warm group. The rate of carbon dioxide (CO2) release in the perfusate followed a similar trend to the oxygen
consumption, and the adenosine triphosphate (ATP) levels reached higher figures at the end of the 6 hours of perfusion in the cold-to-
warm group than with the HOPE+NMP. Panel B represents parameters of metabolic function of the organs during the perfusion.
During the hypothermic phase, lactate levels increased slightly for the livers that had D-HOPE and were constant throughout HOPE.
After rewarming, the lactate peak was comparable between groups, and then the lactate clearance was more effective in the cold-to-warm
group resulting in similar levels at the end of the perfusion. There was evidence of glycogenolysis at the beginning of the D-HOPE
perfusion, and thereafter the organs start to consume glucose during the NMP phase. For the HOPE+NMP group, there was a sudden
drop related to perfusate change at 2-hour perfusion and then the livers start to metabolise glucose during the NMP phase. Perfusate pH
was similar between groups during the perfusion. Three livers in each group produced bile during the perfusion (Panel C). The bile pH
was comparable between them, as was the glucose content. In the graphs, dots represent individual organs at the time points, and the
line is the median of the values for each group. For the bar graph, the median and interquartile range are represented.
https://doi.org/10.1371/journal.pone.0224066.g003
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the hypothermic phase (5.5 [2.4–6.9] vs. 9.8 [7.5–11.3] mmol/L, p = 0.01). After rewarming,
the lactate peak was similar between groups (HOPE+NMP 9.1 [5.7–10.0] vs. cold-to-warm
10.2 [7.9–12.3] mmol/L, p = 0.55). Both groups metabolised lactate effectively with rewarming
and NMP, achieving comparable values at the end of the perfusion (HOPE+NMP 0.8 [0.3–1.4]
vs. cold-to-warm 0.7 [0.2–1.4] mmol/L, p = 0.84).
Venous perfusate glucose was also comparable between groups at the commencement of
the hypothermic phase (HOPE+NMP 10.3 [9.6–10.1] vs. cold-to-warm 11.6 [11.2–12.6]
mmol/L, p> 0.99). For the HOPE+NMP group, there was a slow concentration increase dur-
ing the hypothermic phase and then a drop (related to the perfusate fluid replacement). After 2
hours of NMP, the livers started to consume glucose from the perfusate and both groups
reached similar figures at the end of 6 hours perfusion (HOPE+NMP 27.1 [14.1–40.0] vs. cold-
to-warm 24.5 [21.9–31.8] mmol/L, p = 0.15). Bile production at 6 hours of perfusion was simi-
lar for both groups (HOPE+NMP 5.2 mL/kg liver vs. cold-to-warm 3.2 mL/kg liver). Fig 3 out-
lines these results in further detail.
Finally, all five livers submitted to the HOPE+NMP protocol were deemed viable at the end
of the NMP phase and four of five in the cold-to-warm group. The non-viable liver (cold-to-
warm 3) was from a 55-year-old brain-stem dead donor with a donor risk index of 2.0 and
more than 13 hours of cold ischaemia time. Information surrounding the fulfilment of the via-
bility criteria are presented in Table 3.
Histological assessment
Histologically, there were no signs of pre-existing acute or chronic liver disease at the begin-
ning of the perfusion in both groups. In terms of severity of macrovesicular steatosis, two livers
in the HOPE+NMP were mildly steatotic (5–30%) and two were moderately steatotic (30–
Fig 4. Vascular parameters throughout the perfusion protocols. Panel A shows hepatic artery vascular parameters. The flow
was higher for the HOPE+NMP group, despite slightly higher pressures used for the cold-to-warm group in an attempt to
overcome the higher vascular resistance. A similar trend was seen for the portal vein vascular parameters (Panel B). The cold-to-
warm group had higher vascular resistance mainly during the hypothermic phase, which improved during the rewarming. The
higher vascular resistance required increases in the perfusion pressures, although the vascular flows were still lower during the
initial period of the NMP phase. In the graphs, dots represent individual organs at the time points and the line is the median of
the values for each group.
https://doi.org/10.1371/journal.pone.0224066.g004
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60%) in the cold-to-warm group. All other organs were non-steatotic (< 5%). At the end of
the 6 hours of perfusion, none of the livers exhibited areas of parenchymal necrosis, congestion
or cytoplasmic vacuolization. Additional details are shown in Fig 5.
Immunohistochemical assessment of oxidative stress and tissue
inflammation
The expression of tissue markers of oxidative injury and activation of inflammatory cells were
comparable for the two groups at the start of the perfusion. During the 6 hours of perfusion,
there was an overall decrease in the tissue expression of markers of oxidative injury, UCP2
(p = 0.48) and 4-HNE (p = 0.43). These markers were present mainly in hepatocytes. Consider-
ing downstream activation of the inflammatory cascade, the expression of CD14, part of the
signalosome of toll-like receptor 4, decreased in the HOPE+NMP group and was stable for the
cold-to-warm group, however, the difference was not statistically significant (p = 0.08). Tissue
inflammatory response was assessed by the expression of CD11b on activated polymorphonu-
clear leukocytes (neutrophils and monocytes/macrophages) and VCAM-1 on activated endo-
thelial cells. Its levels of expression decreased similarly between the two groups for both
CD11b (p = 0.80) and VCAM-1 (p = 0.85). Data are presented in Fig 6.
Discussion
In the present study, we have shown that the combined protocol of HMP and NMP—
D-HOPE with sequential slow COR and NMP—using a single HBOC-based perfusate from
cold to warm was associated with enhanced ATP synthesis, low tissue expression of markers of
oxidative tissue injury and activation of inflammatory cells, similarly to a previously published
interrupted combined protocol [8]. Whilst the use of a single perfusate throughout the entire
perfusion simplified the logistics of combining HMP and NMP with a slow and controlled
rewarming period, it was associated with high vascular resistance and low flow dynamics,
mainly during the hypothermic phase. However, this difference did not affect either tissue oxy-
genation or the enhancement of the bioenergetic status of the organs during the hypothermic
phase and allowed effective recovery of the metabolic function of the organs during the nor-
mothermic phase.
Recent studies have shown that the combination of a short-term period of HOPE can
improve the metabolic parameters of discarded high-risk ECD livers, as evaluated by a subse-
quent period of NMP [8, 10]. Whilst HMP replenishes cellular energy stores and mitigates
Table 3. Viability criteria achievement by the livers in each group.
Criteria Cold-to-Warm
(n = 5)
HOPE+NMP
(n = 5)
Lactate clearance (� 2.5 mmol/L) 4 (80%) 5 (100%)
pH > 7.3 perfusate 4 (80%) 2 (40%)
Glucose metabolism 3 (60%) 4 (80%)
HA flow (> 150 mL/min) 5 (100%) 5 (100%)
PV flow (> 500 mL/min) 5 (100%) 5 (100%)
Homogeneous perfusion/ soft parenchyma 5 (100%) 5 (100%)
Bile production 3 (60%) 3 (60%)
Viable liver 4 (80%) 5 (100%)
Abbreviations: HOPE: hypothermic oxygenated perfusion of the liver; NMP: Normothermic machine perfusion of
the liver; HA: hepatic artery; PV: portal vein
https://doi.org/10.1371/journal.pone.0224066.t003
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ischaemia-reperfusion injury, NMP offers full metabolic support to donor organs, thereby
allowing metabolic functioning assessment. Importantly, tests to assess liver function during
HMP are still not readily available. The use of nuclear magnetic resonance spectroscopy to
determine the bioenergetic status of organs during perfusion or to analyse perfusate composi-
tion are possibilities to be further investigated [30–32].
A previous study that performed D-HOPE on human livers using UW-MPS as perfusate
reported, at 2 hours of perfusion, median flows of 365 mL/min for PV and 84 mL/min for HA
[5]. Our experiments utilised the same perfusion device and applied the same protocol in
terms of perfusion pressures and temperature for the D-HOPE phase. However, using an
HBOC-based perfusate, we accomplished lower median vascular flows at 2 hours of D-HOPE
Fig 5. Histological assessment of the perfused organs. Panel A shows two haematoxylin—eosin (H&E)-stained
paraffin-embedded sections at the end of the perfusion run. The left-hand picture is a large portal tract showing well-
preserved bile duct (arrow), artery (circle) and portal vein (arrowhead). A similar picture was seen for smaller
intrahepatic portal tracts in the right-hand picture, where the same well-preserved structures can be identified; and,
interestingly, the presence of the Hemopure1-based perfusate can be visualized (asterisk) in the vein, artery and even
in the sinusoids. Panel B shows the change in glycogen content over time. The first figure on the left shows one liver
from the cold-to-warm group at time 0 with severely depleted glycogen stores; at the end of 6 hours of perfusion, this
was slightly replenished. The graph compares the dynamic changes in glycogen content between groups.
https://doi.org/10.1371/journal.pone.0224066.g005
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(150 mL/min and 42 mL/min, respectively). Median vascular arterial resistance at the same
time point was proportionally higher for the livers of our experiment (0.4 mmHg/mL/min/kg)
than with this previous study (approximately 0.2 mmHg/mL/min/kg). Importantly, similar
vascular dynamic parameters can be observed during D-HOPE in the results of the first pilot
clinical study using an HBOC-based perfusate for a combination of hypothermic and normo-
thermic MP [9]. Altogether, these findings suggest a possible association between the use of an
HBOC-based perfusate at 10 ˚C, higher vascular resistance and reduced flow. However, during
NMP, vascular parameters improved, and they were similar between the groups at the end of
the perfusion run.
The association between HBOC and impaired microcirculation has been reported previ-
ously and diverse theories were proposed in an attempt to explain this [33]. It has been sug-
gested that, based on their small size, HBOC molecules may be able to permeate into the
subendothelial space and acellular haemoglobin consumes nitric oxide (NO) produced by
Fig 6. Immunohistochemical assessment of oxidative tissue injury and activation of the inflammatory cascade.
Panel A shows the tissue expression of the uncoupling protein 2, a marker for reactive oxygen species (ROS)
generation; the left-hand picture shows a moderate diffuse reaction of the staining at time 0, mainly localised at peri-
portal areas, which changed to a mild reaction at the end of the 6 hours perfusion. The graph on the right shows the
variation in the two groups at these time points. This downregulation in ROS production is associated with a reduction
in tissue expression of 4-hydroxynonenal (4-HNE) (Panel B), an established marker for lipid peroxidation during
oxidative stress. The lowered oxidative injury decreases the tissue expression of the cluster of differentiation (CD)14 in
macrophages (Panel C). CD14 is part of the signalosome of the toll-like receptor 4, which in turn leads to the activation
of inflammatory and endothelial cells, perpetuating and aggravating tissue injury. In accordance, a downward trend
can be seen during the perfusion in the presence of activated leukocytes, identified by the expression of the CD11b
(Panel D) and activated endothelial cells, as represented by the expression of the vascular cell adhesion molecule 1
(VCAM-1) (Panel E). Therefore, both combined protocols exhibited a similar decreasing trend in the expression of
markers of ischaemia-reperfusion injury during the perfusion. In the graphs, dots represent individual organs at the
time points, and the line is the median of the values for each group.
https://doi.org/10.1371/journal.pone.0224066.g006
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endothelial cells, thereby preventing its biological vasodilatory effect [34, 35]. Alternatively,
the low viscosity of HBOCs may affect the regulation of flow within the microcirculation
[36, 37]. Mechanistically, the lower shear stress may potentially decrease the production of
NO and, therefore, have an impact of vasoconstriction [33, 38]. Finally, the autoregulatory
theory proposes that terminal arterioles adjust flow according to needs based on PO2 levels
[39, 40]. HBOC would potentially be delivering high concentrations of oxygen at this site,
paradoxically triggering vasoconstriction. Whether these theories explain the effect observed
in our study remains to be seen and requires further investigation. The PO2 used for the
referred UW-MPS D-HOPE study (60 kPa) [5] was the same as that for our HBOC-based
perfusate. However, we do not have comparative data regarding the amount of oxygen deliv-
ered at the level of terminal arterioles in each of these models. In addition, in this study, we
are unable to comment on the difference in viscosity between Hemopure1 and UW-MPS at
10 ˚C. Till now, the theory that acellular haemoglobin scavenges the NO produced in the
subendothelial space remains plausible; however, MetHb levels were stable during HMP,
contrary to what would be expected—NO binds to the oxygen sites in haemoglobin, thus
generating MetHb.
More importantly, despite these differences in vascular parameters, the enhanced oxygen
delivery of HBOCs is likely to have balanced it because adequate oxygen supply was offered to
the cells. Both groups showed a reduction in mitochondrial respiration, as represented by a fall
in the oxygen requirements associated with lowered CO2 production during the hypothermic
phase. These findings were associated with enhanced mitochondrial oxidative function and
ATP synthesis. This improved mitochondrial oxidative function resulted in lower oxidative tis-
sue injury and activation of inflammatory cells mitigating reperfusion injury during rewarm-
ing. Similar findings were reported previously using HOPE and D-HOPE techniques without
the use of an oxygen carrier in the perfusate [5, 30]. The initial lactate levels differed slightly
between groups at the beginning of the perfusion as a result of varied perfusate composition.
Whilst those levels were flat during HOPE, they increased slightly during the first hour of
D-HOPE. A similar initial trend was described in previous publications [4, 5, 9, 11]. Impor-
tantly, this initial elevation is most likely related to an early flush out of the organs because in
isolation, without other markers of reduced perfusion, lactate does not reflect anaerobic
metabolism.
Previous clinical studies have reported minor increases in MetHb levels after transfusion
of Hemopure1 in humans [41, 42]. MetHb is an oxidized form of haemoglobin that cannot
bind oxygen and has a reduced ability to release oxygen to tissues [43]. Physiologically, eryth-
rocyte enzymes reduce the MetHb formed, keeping levels lower than 2% [44]. Clinically, lev-
els under 15% are only associated with greyish skin without further complications [43, 44].
In the context of MP, a previous report on a porcine model indicated stable MetHb levels of
approximately 2% during subnormothermic MP [13]. We established similarly stable levels
during HMP and rewarming, nevertheless, during NMP, MetHb levels rose steadily at a sim-
ilar rate for both groups, reaching median levels of around 7% at the end of the perfusion.
Despite this increase, there was no suggestion of any ischaemic injury to the livers until 6
hours of perfusion. Data on the half-life of the product in this scenario as well as its clearance
is still missing. A recent study has proposed that administration of glutathione, vitamin C or
addition of extra Hemopure1 could potentially be used to overcome issues associated with
increasing MetHb concentrations [9], nevertheless, further studies are needed to confirm
this hypothesis.
To explore fully the advantages of having a perfusate that could be used in a wide range of
temperatures, we incorporate a COR period in the HBOC-based perfusate group. This tech-
nique permits avoiding subtle changes in the temperature of the organs up to 20 ˚C and was
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shown to be beneficial for mitochondrial function, yielding optimized results in a clinical
study [15]. We have employed the same protocol as that clinical study in our experiments,
with the major difference being the HBOC-based perfusate instead of Custodiol-N (Dr. Ko¨hler
Chemie, Bensheim, Germany) used by the original authors. During this phase, no significant
differences were seen in terms of perfusion parameters or liver metabolism features.
The current work has also shown that while an oxygen carrier-free-based perfusate was
equally effective during the hypothermic phase, it is possible to use a single HBOC-based
perfusate within a range of temperatures in the setting of MP of donor livers. This can be
logistically advantageous considering the combination of HMP and NMP techniques
because it eliminates the need for perfusate exchange and can increase the clinical applicabil-
ity of the combined protocol. Despite an effect on flow dynamics with higher vascular resis-
tances and lower flows, the enhanced capacity of oxygen delivery of Hemopure1 potentially
prevented any harmful effects to the organs. Such findings facilitate and support the safety of
a combined protocol of MP using a single HBOC-based perfusate throughout, which can
potentially improve the metabolic functions of high-risk discarded ECD livers, and are in
accordance with the two clinical series reporting the use of a similar protocol of MP prior to
transplantation [9, 11]. In these aforementioned studies, the Groningen group noted the
transplantation of ECD donor livers after performing a protocol of D-HOPE+COR+NMP
using a single HBOC-based perfusate; the authors concluded that this method is feasible,
that HBOC may possibly be a safe alternative to red blood cells for ex situ MP of the liver,
and also suggested that this protocol may increase the number of transplantable livers [9,
11]. Despite similarities, the present study differentiates itself positively because it brings
unique methodological features (strict adherence to originally described D-HOPE and COR
protocols, including perfusion pressures [5, 15]), applies alternative clinically validated via-
bility criteria during NMP for transplantation of discarded human donor livers [19], uses as
a control group a previously published combined protocol of HMP and NMP [8], and, more
importantly, undertakes a careful histopathological analysis of hepatocyte injury and immu-
nohistochemical assessment of oxidative stress and tissue inflammation, as well as assess-
ment of tissue ATP levels.
The present study does have limitations. First, the scarcity of human donor organs for
research limits the sample size, which, in turn, limits the power of the statistical analysis. Sec-
ond, the organs were not transplanted, therefore viability remains theoretical, and the singular-
ity of human donor livers makes the experimental groups imperfectly matched. The
uninterrupted cold-to-warm MP protocol using an HBOC-based perfusate was compared
with a previously published combination of HMP+NMP, and the differences in the perfusate
composition and technique employed limited isolated comparison of HMP techniques exclu-
sively. Replacement of the perfusate, which may reduce toxic metabolites (e.g., cytokines), is a
potential confounding factor for the HOPE+NMP group; however, this analysis was beyond
the scope of the present study. We were unable to evaluate transaminases or other markers of
oxidative stress in the perfusate because the free haemoglobin concentration in the Hemo-
pure1-based perfusate exceeded the maximum haemolytic index tolerance for our hospital
clinical laboratory assessment, and we were unable to measure those subsequently by alterna-
tive methods from rethawed frozen samples. In addition, the absolute values and proportional
ATP increase were lower than those reported by other studies performing D-HOPE on human
livers [5]. This is most likely related to a longer cold ischaemia time in our study because this
can underestimate ATP readings. Moreover, the absence of further data regarding bile duct
histology, bile properties at time points other than 6 hours allied to the inability of some of the
organs to produce bile, limit our interpretation of suggested markers for bile duct injury dur-
ing MP, such as bile pH [45, 46].
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Conclusion
Despite the changes in flow dynamics and vascular resistance, the uninterrupted combined
protocol of HMP and NMP using an HBOC-based perfusate from cold to warm was associated
with enhanced ATP synthesis, low tissue expression of markers of oxidative tissue injury and
activation of inflammatory cells, similarly to an interrupted combined protocol. However, the
use of a single perfusate facilitated the combination of HMP and NMP and eliminated entirely
any concerns of exposing the organs to additional unnecessary ischaemia time required for
perfusate exchange and, thus, may potentially increase the clinical applicability of the com-
bined protocol.
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